Project Grant HT94252311073
Award Date
9/30/23
Completion Date
9/29/25
Dollars Obligated
$624K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43205, USA
Similar Awards
This federal Project Grant award of $1,317,452.00 from the Defense Health Agency (DHA) was provided to the Research Institute at Nationwide Children's Hospital under the Military Medical Research and Development program (CFDA 12.420). The funding supports a 4-year research project titled "MORE EFFECTIVE, KEEPING IT SAFE: REPEAT OHSV TREATMENT FOR GLIOMA" that commenced on August 15, 2023 and is scheduled for completion by August 14, 2027. The Research Institute at Nationwide Children's...
The federal Project Grant award of $624,000.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award is for a project titled "COMPREHENSIVE IN VIVO PHENOTYPING OF FUSION-DRIVEN PEDIATRIC RHABDOMYOSARCOMAS" to be conducted by the Research Institute at Nationwide Children's Hospital in Columbus, Ohio. The project aims to advance pediatric healthcare through innovative research on pediatric rhabdomyosarcomas, a...
The Defense Health Agency awarded a $1,249,009 Project Grant to the Research Institute at Nationwide Children's Hospital under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on August 15, 2023, funds a 4-year project titled "MORE EFFECTIVE, KEEPING IT SAFE: REPEAT OHSV TREATMENT FOR GLIOMA" to conduct medical research and development related to improving treatments for glioma, a type of brain cancer. As a non-profit research institute, the...
The Defense Health Agency awarded a $1,528,727.00 Project Grant to Children's Research Institute, a subsidiary of Children's National Medical Center, to develop SGT-53, a novel nanomedicine that crosses the blood-brain barrier and augments immunotherapeutic response in pediatric brain cancers. This grant, funded through the Military Medical Research and Development program (CFDA 12.420), supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the...
This Project Grant award for $616,710.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports the Children's Research Institute in Washington, D.C. in designing effective adoptive immunotherapy for high-risk pediatric medulloblastoma. The research aims to develop a rational combination with MRI-guided focused ultrasound technology to enhance this innovative cancer treatment approach. The award period runs from August 1, 2024...
This $713,818 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the Research Institute at Nationwide Children's Hospital in Columbus, Ohio to characterize novel patient-specific modeling systems for NF2 disease research and therapeutic testing. The project will be conducted from September 1, 2024 through August 31, 2027. The Research Institute has extensive experience delivering federal research...
The Research Institute at Nationwide Children's Hospital will receive $8.5 million over four years from the Defense Health Agency under the Military Medical Research and Development program to compare the long-term efficacy of tissue-engineered vascular grafts versus polytetrafluoroethylene conduits using an established preclinical model. The award, issued on September 30, 2022, will support research to transform military and public health care through innovative medical solutions for...
This $1,339,955 Project Grant was awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research focused on identifying and overcoming resistance in the use of donor-derived ex vivo expanded natural killer (NK) cells and haploidentical hematopoietic cell transplantation (haplo-HCT) in children and young adults with high-risk acute myeloid leukemia (AML). The prime awardee is the...
The Defense Health Agency has awarded a $1,746,810 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Children's Hospital of Philadelphia (CHOP) Research Institute. The 3-year grant, effective July 1, 2025 through June 30, 2028, will support research on combination therapy for high-risk, MYCN-amplified neuroblastoma, a rare and aggressive form of pediatric cancer. CHOP, a renowned pediatric medical center and research institution, will...
This $1,354,428 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) will fund a family-centered e-health intervention to promote patient and caregiver well-being in adolescent and emerging adult pediatric brain tumor survivors. The grant was awarded to the Children's Hospital Medical Center in Cincinnati, Ohio, which will serve as the prime awardee. The project duration is from September 1, 2024 to August 31, 2028. The...